Kamel Mohammedi

3.6k total citations
126 papers, 2.4k citations indexed

About

Kamel Mohammedi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Clinical Biochemistry. According to data from OpenAlex, Kamel Mohammedi has authored 126 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Surgery and 23 papers in Clinical Biochemistry. Recurrent topics in Kamel Mohammedi's work include Diabetes Treatment and Management (24 papers), Advanced Glycation End Products research (21 papers) and Diabetic Foot Ulcer Assessment and Management (20 papers). Kamel Mohammedi is often cited by papers focused on Diabetes Treatment and Management (24 papers), Advanced Glycation End Products research (21 papers) and Diabetic Foot Ulcer Assessment and Management (20 papers). Kamel Mohammedi collaborates with scholars based in France, United States and Canada. Kamel Mohammedi's co-authors include Ronan Roussel, Michel Marre, Louis Potier, Charbel Abi Khalil, Gilberto Velho, Frédéric Fumeron, Samy Hadjadj, Jassim Al Suwaidi, Marwan M. Refaat and Amin Jayyousi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Circulation Research.

In The Last Decade

Kamel Mohammedi

121 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamel Mohammedi France 29 1.1k 717 469 459 420 126 2.4k
Lung‐An Hsu Taiwan 27 584 0.6× 625 0.9× 483 1.0× 689 1.5× 410 1.0× 139 2.7k
Masanori Iwase Japan 29 965 0.9× 642 0.9× 395 0.8× 540 1.2× 214 0.5× 110 2.6k
Tatsuya Maruhashi Japan 30 597 0.6× 738 1.0× 605 1.3× 1.4k 3.0× 352 0.8× 146 3.1k
Giuseppe Seghieri Italy 32 1.3k 1.2× 618 0.9× 560 1.2× 490 1.1× 186 0.4× 115 3.3k
W Grzeszczak Poland 31 969 0.9× 429 0.6× 587 1.3× 637 1.4× 243 0.6× 298 3.2k
R.J. Heine Netherlands 27 845 0.8× 516 0.7× 539 1.1× 516 1.1× 197 0.5× 43 2.8k
K. C. B. Tan Hong Kong 30 1.3k 1.2× 725 1.0× 475 1.0× 430 0.9× 148 0.4× 90 2.9k
Daniel Gordin Finland 31 1.0k 1.0× 293 0.4× 304 0.6× 849 1.8× 229 0.5× 93 2.7k
Ravi Nistala United States 28 792 0.8× 346 0.5× 533 1.1× 652 1.4× 139 0.3× 59 2.1k
Andreas Tomaschitz Austria 33 873 0.8× 554 0.8× 452 1.0× 859 1.9× 379 0.9× 80 2.9k

Countries citing papers authored by Kamel Mohammedi

Since Specialization
Citations

This map shows the geographic impact of Kamel Mohammedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamel Mohammedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamel Mohammedi more than expected).

Fields of papers citing papers by Kamel Mohammedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamel Mohammedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamel Mohammedi. The network helps show where Kamel Mohammedi may publish in the future.

Co-authorship network of co-authors of Kamel Mohammedi

This figure shows the co-authorship network connecting the top 25 collaborators of Kamel Mohammedi. A scholar is included among the top collaborators of Kamel Mohammedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamel Mohammedi. Kamel Mohammedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohammedi, Kamel, Pierre‐Jean Saulnier, Samy Hadjadj, et al.. (2025). Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population. The Journal of Clinical Endocrinology & Metabolism. 110(10). e3334–e3342. 1 indexed citations
2.
Bérard, Annie M., Florian Poullenot, Kamel Mohammedi, et al.. (2025). Low serum albumin and severe undernutrition in subjects with diabetes and weight loss. Nutrition. 139. 112883–112883. 1 indexed citations
3.
Rubin, Sébastien, et al.. (2024). Increased risk of renal events in people with diabetic foot disease: A longitudinal observational study. Diabetes & Metabolism. 50(4). 101536–101536. 4 indexed citations
4.
Mohammedi, Kamel, Michel Marre, & François Alhenc‐Gelas. (2024). Genetic predisposition to nephropathy and associated cardiovascular disease in people with type 1 diabetes: role of the angiotensinI-converting enzyme (ACE), and beyond; a narrative review. Cardiovascular Diabetology. 23(1). 453–453. 3 indexed citations
5.
Gatta‐Cherifi, Blandine, Kamel Mohammedi, Christine Poitou, et al.. (2024). Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial. European Journal of Endocrinology. 190(4). 257–265. 8 indexed citations
6.
Mohammedi, Kamel, Sylvie Salenave, Dominique Maiter, et al.. (2024). Personalized Noninvasive Diagnostic Algorithms Based on Urinary Free Cortisol in ACTH-dependant Cushing's Syndrome. The Journal of Clinical Endocrinology & Metabolism. 109(11). 2882–2891. 7 indexed citations
7.
Harris, Stewart B., Kamel Mohammedi, Maureen Carlyle, et al.. (2023). Patient and physician perspectives and experiences of basal insulin titration in type 2 diabetes in the United States: Cross‐sectional surveys. Diabetes Obesity and Metabolism. 25(12). 3478–3489. 2 indexed citations
8.
Mohammedi, Kamel, Jérôme Bertherat, Gérald Raverot, et al.. (2023). Evidence of Persistent Mild Hypercortisolism in Patients Medically Treated for Cushing Disease: the Haircush Study. The Journal of Clinical Endocrinology & Metabolism. 108(10). e963–e970. 11 indexed citations
9.
Mohammedi, Kamel, et al.. (2023). Once‐weekly semaglutide use in patients with type 2 diabetes: Results from the SURE France multicentre, prospective, observational study. Diabetes Obesity and Metabolism. 25(7). 1855–1864. 17 indexed citations
10.
Potier, Louis, Kamel Mohammedi, Pierre‐Jean Saulnier, et al.. (2022). Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 Diabetes. Diabetes Care. 45(7). 1631–1639. 2 indexed citations
11.
Mohammedi, Kamel, Michel Marre, Samy Hadjadj, Louis Potier, & Gilberto Velho. (2022). Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes. Cells. 11(24). 4131–4131. 2 indexed citations
12.
Mohammedi, Kamel, Séverine Dubois, Pierre Gourdy, et al.. (2021). ACE I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes. Diabetes Care. 44(6). 1377–1384. 6 indexed citations
13.
Saulnier, Pierre‐Jean, Louis Potier, Fabrice Schneider, et al.. (2020). Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 Diabetes. Diabetes Care. 43(11). 2751–2759. 11 indexed citations
14.
Potier, Louis, Ronan Roussel, Gilberto Velho, et al.. (2019). Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use. Diabetologia. 62(6). 939–947. 36 indexed citations
15.
Meijer, Esther, Lyanne M. Kieneker, Sofia Enhörning, et al.. (2018). Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population. JCI Insight. 3(13). 38 indexed citations
16.
Velho, Gilberto, Stéphanie Ragot, Pierre‐Jean Saulnier, et al.. (2018). Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes. Cardiovascular Diabetology. 17(1). 110–110. 38 indexed citations
17.
Mohammedi, Kamel, Jean‐Philippe Bastard, Soraya Fellahi, et al.. (2017). T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes. Nephrology Dialysis Transplantation. 32(12). 1987–1993. 3 indexed citations
18.
Hansel, Boris, Dominique Bonnefont‐Rousselot, Alexina Orsoni, et al.. (2016). Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels. Journal of clinical lipidology. 10(5). 1172–1181. 11 indexed citations
19.
Mohammedi, Kamel, Thiago A. Patente, Naïma Bellili-Muñoz, et al.. (2015). Glutathione peroxidase-1 gene (GPX1) variants, oxidative stress and risk of kidney complications in people with type 1 diabetes. Metabolism. 65(2). 12–19. 40 indexed citations
20.
Mohammedi, Kamel, Bertrand Yersin, Philippe Staeger, & Pierre‐Nicolas Carron. (2010). Pneumothorax sur prise de cocaïne. IRIS. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lung‐An Hsu Breakdown of academic impact, for papers by Masanori Iwase Breakdown of academic impact, for papers by Tatsuya Maruhashi Breakdown of academic impact, for papers by Giuseppe Seghieri Breakdown of academic impact, for papers by W Grzeszczak Breakdown of academic impact, for papers by R.J. Heine Breakdown of academic impact, for papers by K. C. B. Tan Breakdown of academic impact, for papers by Daniel Gordin Breakdown of academic impact, for papers by Ravi Nistala Breakdown of academic impact, for papers by Andreas Tomaschitz
Rankless by CCL
2026